Brain Stimulation for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether stimulating a part of the brain can help people feel fuller and lose weight. It uses electrical stimulation on the dorsolateral prefrontal cortex, a brain area linked to satiety, and tracks changes in eating habits and weight over four weeks. Participants will receive either real transcranial direct current stimulation (tDCS) or sham (fake) stimulation and may also attend weight loss counseling. The trial specifically seeks obese, non-diabetic individuals in Phoenix who haven't experienced major weight fluctuations or used appetite-affecting medications recently. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group of people.
Will I have to stop taking my current medications?
The trial requires that participants have not used medications affecting metabolism and appetite in the last three months. If you are currently taking such medications, you may need to stop them to be eligible for the study.
What prior data suggests that transcranial direct current stimulation (tDCS) is safe for treating obesity?
Research shows that transcranial direct current stimulation (tDCS) is generally safe. Past studies have used tDCS without problems to help reduce food cravings in individuals who are overweight or obese. Participants often experience a mild tingling under the electrodes, but serious side effects are rare. The procedure is non-invasive, meaning it doesn't involve surgery or inserting anything into the body.
More specifically, studies have found that tDCS can help control food cravings and improve mental well-being related to eating habits. While researchers are still determining the best way to use tDCS for obesity, current evidence supports its safety in clinical research.12345Why are researchers excited about this trial's treatments?
Unlike the standard treatments for obesity, which often include lifestyle modifications, medications, and surgery, Transcranial Direct Current Stimulation (TDCS) introduces a non-invasive brain stimulation technique. Researchers are excited about TDCS because it targets brain areas involved in appetite control and decision-making, potentially reducing the desire to overeat. This method offers a new mechanism of action compared to traditional approaches, aiming to influence neural activity directly. Additionally, TDCS is a painless, non-surgical option, which could make it more accessible and appealing for individuals seeking alternatives to conventional obesity treatments.
What evidence suggests that transcranial direct current stimulation (tDCS) might be an effective treatment for obesity?
Research has shown that Transcranial Direct Current Stimulation (tDCS), one of the treatments studied in this trial, can help reduce food cravings in people who are overweight or obese. Studies have found that tDCS, when applied to the prefrontal cortex (a brain area involved in self-control), can lessen the desire to eat. This treatment has also been linked to better control over food cravings and improved mental well-being related to eating habits. The stimulation appears to change how the brain responds to food signals, making it easier to avoid overeating. Overall, early findings suggest that tDCS could effectively manage obesity by reducing the urge to eat excessively. Participants in this trial may receive either active tDCS stimulation or a sham/no-stimulation as part of the study.23678
Who Is on the Research Team?
Marci E Gluck, Ph.D.
Principal Investigator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Are You a Good Fit for This Trial?
This trial is for non-diabetic, right-handed adults aged 18-60 living in Phoenix, AZ with obesity (BMI ≥ 25 kg/m² and weight <350 lbs). Participants should have had a stable weight for the last three months. Exclusions include postmenopausal women, those with conditions affecting appetite or metabolism, recent medication use that affects metabolism/appetite, substance abuse issues, unstable medical conditions, contraindications for MRI scans or any other condition deemed unsafe by the investigator.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Inpatient Evaluation
Participants are admitted to the NIH inpatient unit for tests including meal tests, blood and urine tests, glucose tolerance test, weight measurement, psychological assessments, and DEXA scan
Treatment
Participants receive either real or sham transcranial direct current stimulation (tDCS) while following a reduced-calorie diet
Follow-up
Participants are monitored for weight changes and other outcomes
Long-term Follow-up
Participants return for weight measurements and assessments
What Are the Treatments Tested in This Trial?
Interventions
- Sham/no-stimulation
- Transcranial Direct Current Stimulation (TDCS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lead Sponsor